Seismyc DETECT. DECODE. TRADE. LIVE
← All stories
Markets 1 sources

Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss

Covered by 1 source · 1 article

Unless the price of ZEC rallies, Cypherpunk Technologies says it will need to raise a lot of money to pay for its upcoming FDA trials. The post Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss appeared first on Protos .

Covered by
Protos

All coverage

Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss
Protos 2h ago

Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss

Unless the price of ZEC rallies, Cypherpunk Technologies says it will need to raise a lot of money to pay for its upcoming FDA trials. The post Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss appeared first on Protos .